Zobrazeno 1 - 10
of 40
pro vyhledávání: '"Margarita Angerosa"'
Publikováno v:
Journal of Clinical and Diagnostic Research, Vol 9, Iss 12, Pp FF08-FF12 (2015)
Introduction: Ferric carboxymaltose is a next-generation polynuclear iron(III)-hydroxide carbohydrate complex for intravenous iron therapy belonging to the class of so-called non-biological complex drugs. The product characteristics and therapeut
Externí odkaz:
https://doaj.org/article/94b835bb82074a44a17e32975c32ccf5
Publikováno v:
CONICET Digital (CONICET)
Consejo Nacional de Investigaciones Científicas y Técnicas
instacron:CONICET
Drug Design, Development and Therapy
Consejo Nacional de Investigaciones Científicas y Técnicas
instacron:CONICET
Drug Design, Development and Therapy
Background: Ferric carboxymaltose (FCM) is a stable, non-dextran-based intravenous iron complex used to treat iron deficiency of various etiologies. As FCM is a nonbiological complex drug and cannot be fully characterized by physicochemical analyses,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c89d094fb3ce8f6bccf0f3eb69831487
https://www.dovepress.com/cardiovascular-liver-and-renal-toxicity-associated-with-an-intravenous-peer-reviewed-article-DDDT
https://www.dovepress.com/cardiovascular-liver-and-renal-toxicity-associated-with-an-intravenous-peer-reviewed-article-DDDT
Publikováno v:
International Journal of Impotence Research. 27:182-190
Oxidative stress and nitrosative stress present in type 2 diabetes mellitus (T2DM) and metabolic syndrome (MS) induce inflammatory response in diverse tissues including cavernous tissue (CT). Heat-shock proteins (HSPs) have an important role in modul
Publikováno v:
BioMetals. 28:279-292
Iron can both induce and inhibit nitrosative stress. Intracellular iron levels play an important role in nitric oxide (NO•) signaling mechanisms. Depending on various factors, such as the cell's redox state and transition metal levels, NO• genera
Autor:
ALBERTO, PALAORO LUIS1,2 luispalaoro@yahoo.com.ar, MARGARITA, ANGEROSA1,2
Publikováno v:
Journal of Cytology. Jan-Mar2014, Vol. 31 Issue 1, p25-31. 7p.
Autor:
Jorge E. Toblli, Margarita Angerosa
Publikováno v:
Drug Design, Development and Therapy
CONICET Digital (CONICET)
Consejo Nacional de Investigaciones Científicas y Técnicas
instacron:CONICET
CONICET Digital (CONICET)
Consejo Nacional de Investigaciones Científicas y Técnicas
instacron:CONICET
With the challenge of optimizing iron delivery, new intravenous (iv) iron-carbohydrate complexes have been developed in the last few years. A good example of these new compounds is ferric carboxymaltose (FCM), which has recently been approved by the
Publikováno v:
CONICET Digital (CONICET)
Consejo Nacional de Investigaciones Científicas y Técnicas
instacron:CONICET
Drug Design, Development and Therapy
Consejo Nacional de Investigaciones Científicas y Técnicas
instacron:CONICET
Drug Design, Development and Therapy
Iron deficiency anemia is a frequent complication in clinical conditions such as chronic kidney disease, chronic heart failure, inflammatory bowel disease, cancer, and excessive blood loss. Given the ability of iron to catalyze redox reactions, iron
Publikováno v:
Int. Journal of Clinical Pharmacology and Therapeutics. 50:573-583
Objectives The originator iron polymaltose complex (Maltofer®, IPC, Vifor International, St. Gallen, Switzerland) has been used for over 30 years to treat iron deficiency anemia. Its physico-chemical properties allow for a controlled release of iron
Publikováno v:
Placenta. 33:81-87
Objective Iron deficiency anemia (IDA) can severely impair the outcome of pregnancy. IDA has been shown to cause oxidative stress, which may be exacerbated by oral iron therapy. In this study, the effects of IDA and its treatment with iron polymaltos
Publikováno v:
Arzneimittelforschung. 61:553-565
The physicochemical characteristics of intravenous iron complexes affect the extent of weakly-bound iron and thus the degree of oxidative stress. The new preparation iron isomaltoside 1000 (IIM) was compared to iron sucrose (IS) and a control group i